Sachiko Yamamoto Selected Research

Sachiko Yamamoto Research Topics

Disease

13	Neoplasms (Cancer) 03/2022 - 05/2008
11	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 02/2009
8	Esophageal Squamous Cell Carcinoma 03/2022 - 01/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 06/2012
3	Hemorrhage 02/2019 - 08/2007
3	Stomach Neoplasms (Stomach Cancer) 06/2016 - 08/2007
2	Obesity 09/2021 - 12/2010
2	Colitis 05/2021 - 04/2021
2	Melena 02/2019 - 08/2007
2	Hematemesis 02/2019 - 08/2007
2	Colorectal Neoplasms (Colorectal Cancer) 03/2016 - 02/2015
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2012 - 08/2010
2	Weight Gain 12/2010 - 11/2004
2	Ulcer 02/2009 - 08/2007
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2022
1	Carcinogenesis 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Inflammation (Inflammations) 05/2021
1	Melanoma (Melanoma, Malignant) 04/2021
1	Lung Neoplasms (Lung Cancer) 04/2021
1	Kidney Neoplasms (Kidney Cancer) 04/2021
1	Diarrhea 04/2021
1	Infections 04/2021
1	Esophageal Perforation 01/2021
1	Retinal Vein Occlusion 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Stomach Ulcer (Gastric Ulcer) 02/2019
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Vomiting 02/2017
1	Motion Sickness (Airsickness) 02/2017
1	Nausea 02/2017
1	Hyperaldosteronism (Conn Syndrome) 01/2017
1	Essential Hypertension 01/2017
1	Esophagitis 10/2016
1	Lymphatic Metastasis 07/2012
1	Chest Pain (Chest Pains) 07/2012
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 02/2012
1	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 02/2012
1	Carcinoma (Carcinomatosis) 06/2011
1	Cardiovascular Diseases (Cardiovascular Disease) 06/2011
1	Insulin Resistance 12/2010
1	Flushing 11/2008

Drug/Important Bio-Agent (IBA)

6	IodineIBA 10/2021 - 05/2008
3	AcidsIBA 02/2019 - 08/2007
2	Immune Checkpoint InhibitorsIBA 05/2021 - 04/2021
2	Docetaxel (Taxotere)FDA Link 01/2021 - 10/2016
2	C-Reactive ProteinIBA 01/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 02/2019 - 08/2007
1	EnzymesIBA 01/2022
1	Aldehyde DehydrogenaseIBA 01/2022
1	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 01/2022
1	Galectin 3 (LGALS3)IBA 09/2021
1	AdipokinesIBA 09/2021
1	Gentian Violet (Violet, Crystal)FDA Link 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	Infliximab (Remicade)FDA Link 04/2021
1	SteroidsIBA 04/2021
1	MetalsIBA 01/2021
1	PlatinumIBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Ranibizumab (Lucentis)FDA Link 01/2020
1	AlbuminsIBA 01/2020
1	Carcinoembryonic AntigenIBA 01/2020
1	1- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA 02/2019
1	PotassiumIBA 02/2019
1	nedaplatinIBA 02/2017
1	AntiemeticsIBA 02/2017
1	Meperidine (Pethidine)FDA LinkGeneric 01/2017
1	Midazolam (Versed)FDA LinkGeneric 01/2017
1	ReninIBA 01/2017
1	Antihypertensive Agents (Antihypertensives)IBA 01/2017
1	AldosteroneIBA 01/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2016
1	XELOXIBA 02/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2015
1	Capecitabine (Xeloda)FDA Link 02/2015
1	AntralIBA 08/2012
1	Analgesics (Analgesic Drugs)IBA 07/2012
1	Insulin (Novolin)FDA Link 12/2010
1	Irbesartan FDA LinkGeneric 12/2010
1	Glucose (Dextrose)FDA LinkGeneric 12/2010
1	S 1 (combination)IBA 03/2009
1	SolutionsIBA 11/2008
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2008

Therapy/Procedure

8	Therapeutics 11/2021 - 10/2005
7	Chemoradiotherapy 03/2022 - 01/2010
5	Esophagectomy 11/2021 - 06/2011
4	Drug Therapy (Chemotherapy) 01/2021 - 03/2009
3	Radiotherapy 03/2022 - 10/2016
2	Endoscopic Hemostasis 10/2022 - 08/2007
2	Stents 01/2021 - 01/2021
1	Lasers (Laser) 02/2019
1	Adjuvant Chemoradiotherapy 01/2019
1	Surgical Instruments (Clip) 06/2016
1	Electrocoagulation (Electrocautery) 03/2016
1	Lymph Node Excision (Lymph Node Dissection) 02/2015
1	Endoscopes 03/2014
1	Induction Chemotherapy 06/2012
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 02/2012
1	Salvage Therapy 06/2011